| Bioactivity | (5S,8R)-HBV-IN-10 is an enantiomer of compound 6 (WO2021204258A1). Compound 6 is a hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM< EC50 ≤0.05 μM). From patent WO2021204258A1, compound 6[1]. |
| Name | (5S,8R)-HBV-IN-10 |
| CAS | 2716907-15-0 |
| Formula | C23H24FN7O |
| Molar Mass | 433.48 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Azabicyclo compound as hepatitis b surface antigen inhibitor. WO2021204252A1. |
(5S,8R)-HBV-IN-10
CAS: 2716907-15-0 F: C23H24FN7O W: 433.48
(5S,8R)-HBV-IN-10 is an enantiomer of compound 6 (WO2021204258A1). Compound 6 is a hepatitis B surface antigen (HBsAg) i
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.